Neutralizing antibodies to interferon-beta may persist after cessation of therapy: What impact could they have?

Chris H. Polman; Joep Killestein; Huub Schellekens

doi:10.1191/135248506ms1284ed

Neutralizing antibodies to interferon-beta may persist after cessation of therapy: What impact could they have?

Chris H. Polman^*, Joep Killestein, Huub Schellekens

^*Corresponding author for this work

Innovation Studies

Vrije Universiteit Amsterdam

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	245-246
Number of pages	2
Journal	Multiple Sclerosis
Volume	12
Issue number	3
DOIs	https://doi.org/10.1191/135248506ms1284ed
Publication status	Published - 2006

Access to Document

10.1191/135248506ms1284ed

Cite this

@article{1e387cfabfee4c8795002ef2df12460f,

title = "Neutralizing antibodies to interferon-beta may persist after cessation of therapy: What impact could they have?",

author = "Polman, {Chris H.} and Joep Killestein and Huub Schellekens",

year = "2006",

doi = "10.1191/135248506ms1284ed",

language = "English",

volume = "12",

pages = "245--246",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Neutralizing antibodies to interferon-beta may persist after cessation of therapy

T2 - What impact could they have?

AU - Polman, Chris H.

AU - Killestein, Joep

AU - Schellekens, Huub

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=33744782041&partnerID=8YFLogxK

U2 - 10.1191/135248506ms1284ed

DO - 10.1191/135248506ms1284ed

M3 - Editorial

C2 - 16764335

AN - SCOPUS:33744782041

SN - 1352-4585

VL - 12

SP - 245

EP - 246

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 3

ER -

Neutralizing antibodies to interferon-beta may persist after cessation of therapy: What impact could they have?

Access to Document

Other files and links

Cite this